Clinical Trial Update: Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial of durvalumab with radiation followed by adjuvant durvalumab in urothelial carcinoma of the bladder; the study has been terminated a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma of the Bladder

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Monika Joshi, MD | Conditions: Urothelial Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-11-27